Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Tracy J Sims, Kristina S Boye, Susan Robinson & Tessa Kennedy-Martin. (2022) Treatment-Related Attributes of Diabetes Therapies and How People with Type 2 Diabetes Report Their Impact on Indicators of Medication-Taking Behaviors. Patient Preference and Adherence 16, pages 1919-1939.
Read now
Read now
Kristina S Boye, Shraddha Shinde, Tessa Kennedy-Martin, Susan Robinson & Vivian T Thieu. (2022) Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative Review. Patient Preference and Adherence 16, pages 23-39.
Read now
Read now
Samaneh Kalirai, Jasmina I Ivanova, Magaly Perez-Nieves, Judith J Stephenson, Irene Hadjiyianni, Michael Grabner, Roy Daniel Pollom, Caroline Geremakis, Beverly L Reed & Lawrence Fisher. (2020) Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States. Diabetes, Metabolic Syndrome and Obesity 13, pages 1023-1033.
Read now
Read now
Michael A. Gibney, David Fitz-Patrick, David C. Klonoff, Shahista Whooley, Betty Lu, Wen Yue & Stanislav Glezer. (2020) User experiences with second-generation 32-gauge × 4 mm vs. thinner comparator pen needles: prospective randomized trial. Current Medical Research and Opinion 36:10, pages 1591-1600.
Read now
Read now
Theresa L. Garnero, Nichola J. Davis, Magaly Perez-Nieves, Irene Hadjiyianni, Dachuang Cao, Jasmina I. Ivanova & Mark Peyrot. (2018) Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy. Postgraduate Medicine 130:4, pages 394-401.
Read now
Read now
Articles from other publishers (13)
Lea Kirstine Lewerenz Skriver, Malene Winther Nielsen, Simone Walther, Jannie Damsgaard Nørlev & Stine Hangaard. (2023) Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review. Journal of Diabetes and its Complications 37:10, pages 108596.
Crossref
Crossref
Nora A. Williams, Stephen A. Brunton & Gregory A. Scott. (2022) CRS Diabetes: An Effective Model for Improving Family Medicine Resident Knowledge, Competence, and Performance in Diabetes Care. Clinical Diabetes 40:1, pages 62-69.
Crossref
Crossref
Jianmin Wu, Fritha Morrison, Zhenxiang Zhao, Ginger Haynes, Xuanyao He, Ayad K. Ali, Maria Shubina, Shervin Malmasi, Wendong Ge, Xiaomei Peng & Alexander Turchin. (2021) Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study. Clinical Diabetes and Endocrinology 7:1.
Crossref
Crossref
Daniela Beatriz Muñoz-López, Verónica Reyes Pérez, Ma. Eugenia Garay-Sevilla & Mónica del Carmen Preciado-Puga. (2020) Validation of an instrument to measure adherence to type 2 diabetes management. International Journal of Clinical Pharmacy 43:3, pages 595-603.
Crossref
Crossref
Luigi Meneghini, Lawrence Blonde, Jasvinder Gill, Arnaud Dauchy, Andrius Bacevicius, Jodi Strong & Timothy S. Bailey. (2020)
Insulin glargine 300 U/
mL
versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of
ACHIEVE
Control, a prospective, randomized, pragmatic real‐life clinical trial
. Diabetes, Obesity and Metabolism 22:11, pages 1995-2003.
Crossref
Crossref
Fu-Shun Yen, James Cheng-Chung Wei, Jia-Sin Liu, Chih-Cheng Hsu & Chii-Min Hwu. (2020) The factors associated with insulin nonpersistence in persons with type 2 diabetes. Diabetes Research and Clinical Practice 167, pages 108356.
Crossref
Crossref
Alan J. Sinclair, Simon R. Heller, Richard E. Pratley, Ran Duan, Robert J. Heine, Andreas Festa & Jacek Kiljański. (2020) Evaluating glucose‐lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial. Diabetes, Obesity and Metabolism 22:8, pages 1231-1242.
Crossref
Crossref
Puhong Zhang, Heng Zhang, Xian Li, Minyuan Chen, Du Wang & Linong Ji. (2020) Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus. Endocrinology, Diabetes & Metabolism 3:2.
Crossref
Crossref
Mark Warren & Donna Steel. (2020) Clinical Use of IDegLira: Initiation to Titration After Basal Insulin. Clinical Diabetes 38:1, pages 62-70.
Crossref
Crossref
Denise Reis Franco, Magaly Perez-Nieves, Jasmina I Ivanova, Dachuang Cao & Marcela Saturnino Caselato Vaz. (2019) Basal insulin persistence in Brazilian participants with T2DM. Revista da Associação Médica Brasileira 65:10, pages 1254-1264.
Crossref
Crossref
Iskandar Idris, Kunal Gulati, Magaly Perez-Nieves, Irene Hadjiyianni, Dachuang Cao, Arash Tahbaz, Jasmina Ivanova & Syed Wasi Hassan. (2019) Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample. Primary Care Diabetes 13:2, pages 106-112.
Crossref
Crossref
Brian M. Frier, Wolfgang Landgraf, Mei Zhang, Geremia B. Bolli & David R. Owens. (2018) Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 20:12, pages 2894-2898.
Crossref
Crossref
Jennifer D. Goldman, Jasvinder Gill, Tony Horn, Timothy Reid, Jodi Strong & William H. Polonsky. (2018) Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program. Diabetes Therapy 9:5, pages 2143-2153.
Crossref
Crossref